The heterodimer-disruptive point mutations found in the β2 (CD18) and β3 subunits in patients with LAD I and Glanzmann’s thrombasthenia (a bleeding disorder), respectively, map to the βA domain and commonly involve residues at the βA-propeller interface87. This evidence concerns the gene ITGB2 and Glanzmann thrombasthenia.